Monoclonal antibodies were produced to a field strain (Mil) of group B coxsackievirus type 4 (CBV-4), and to the prototype JVB strain. Nine were neutralizing antibodies and four were non-neutralizing antibodies with virus-specific activity in indirect immunofluorescence (IF) staining. On the basis of reactivity with the panel of monoclonal antibodies, nine different strains of CBV-4 were found to fall into five distinct antigenic groups. Antigenic variants were produced by using the neutralizing monoclonal antibodies to select variants from the Mil virus stock which were no longer susceptible to the selecting antibody. A high frequency of antigenic variation was seen. By using the variants in cross-neutralization and IF tests with the monoclonal antibodies, it was possible to identify five tentative antigenic sites functional in neutralization; one site appeared to be complex and possibly to consist of overlapping epitopes. Reactivity of the monoclonal antibodies was similar, but not necessarily identical, by neutralization and by IF staining. The antigenic variants were found to differ from the parent Mil strain, and from one another, in their myocarditic and cardiotropic properties in a murine model. Two of the variants produced more extensive cardiac pathology, and two produced higher virus titres in the heart than was produced by the parent strain. One variant was notable for extensive production of necrotic lesions in the myocardium. Four of the variants showed less histopathology and three produced less virus in the heart than was produced by the parent strain.
INTRODUCTION
Laboratory strains of group B coxsackieviruses have been shown in various studies to consist of virus populations which are heterogeneous with respect to biological or antigenic properties (Choppin & Eggers, 1962; Hartig et al., 1983; Richter et al., 1972; Wigand & Sabin, 1962) . A high frequency of antigenic variation within the coxsackievirus B4 serotype was recently demonstrated using monoclonal antibodies (Prabhakar et al., 1982) .
Several findings have suggested that antigenic variation among group B coxsackieviruses might be associated with unique pathological properties or tissue tropisms. The fact that the aetiological agent of an animal disease emerging in 1966, swine vesicular disease, is antigenically related to coxsackievirus type B5 (Graves, 1973; Brown et al., 1976) suggests that group B coxsackieviruses may undergo antigenic variation associated with marked changes in host tropism and pathology. Furthermore, a diabetogenic strain of coxsackievirus B4 (CBV-4) isolated from a human pancreas was more closely related antigenically to a diabetogenic strain selected by passage of the prototype CBV-4 strain in beta cells than to the prototype virus itself (Yoon et al., 1979) . Also, plaque-purified clones derived from a CBV-4 isolate were shown to differ in their abilities to produce viral antigen in islet cells of mouse pancreas (Hartig et al., 1983) .
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METHODS
Viruses. The prototype JVB strain and eight field strains of CBV-4 were used in these studies. The histories and myocarditic properties of these strains are described elsewhere (Cao et al., 1984) . Stock virus preparations were produced in Buffalo green monkey kidney (BGMK) cell cultures.
Monoclonal antibodies to CB V-4. Hybridoma cells secreting monoclonal antibodies to CBV-4 were produced by standard procedures (Oi & Herzenberg, 1980) by fusion of mouse myeloma cells of the NS-1 line with spleen cells of BALB/c mice immunized with the prototype JVB strain or the myocarditic Mil field strain (Cao et al., 1984) . Hybridoma lines secreting antibodies specific for CBV-4 were identified by an enzyme immunofluorescence assay (EIFA) (Forghani et al., 1982) , cloned by the limiting dilution method, and further studied by neutralization and immunofluorescence (IF) staining. Nine clones with neutralizing activity, and four without neutralizing activity, but which showed virus-specific activity in IF assays, were identified. These were used to produce immune ascitic fluids. BALB/c mice 5 to 6 months of age were primed by an intraperitoneal injection of 0.5 ml Pristane, and inoculated 7 to 10 days later with 1 x 107 hybridoma cells. Tumours developed after approximately 2 weeks, and ascitic fluids were collected and clarified by low-speed eentrifugation.
Virus neutralization tests. Neutralizing antibody assays were done by a micro method (Schmidt, 1979) in BGMK cells. Titres were expressed as the highest dilution of immune ascitic fluid, in a volume of 0.05 ml, that inhibited the cytopathic effect of 100 TCID50 of virus. The starting dilution of immune ascitic fluids examined was generally 1 : 32. This was chosen because in initial studies using starting dilutions of 1 : 16, sera that were negative at a 1 : 32 dilution were invariably negative at a dilution of 1 : 16. At dilutions lower than 1 : 16, the immune ascitic fluids were sometimes toxic to celt cultures. In addition to negative neutralization results (titres of < 1 : 32), titres against field strains and antigenic variants that were > 2.5 log~ 0 units lower than those against the homologous or parent virus were taken into account in presenting the neutralization test data, since these differed from the mean homologous titre by more than two standard deviations (see Table 1 ).
Indirect immunofluorescence staining. The antigen substrate for IF staining was prepared by mixing trypsindispersed BGMK cells from infected cultures showing /> 50~ c.p.e, with uninfected cells at a ratio of 1:3. The cells were spotted onto glass slides, and fixed in acetone. Antibody preparations diluted in half-log steps, starting at 1:10, were examined by the standard indirect IF procedure of this laboratory (Riggs, 1979) . All sera were examined against uninfected BGMK cell spots as well as the viral antigen substrate. In addition to negative staining titres of < 1 : 10, titres against field strains or antigenic variants which were > 3 loglo units lower than those against the homologous virus were taken into account in presenting the IF test data, since these differed from the mean homologous titre by more than two standard deviations (see Table 1 ).
Selection of antigenic variants. Nine monoclonal antibodies with neutralizing activity were used to select antigenic variants from the myocarditic field strain, Mil. Seven of these antibodies were produced against the Mil strain, and two were produced against the JVB strain. To select variants in the presence of a neutralizing antibody, serial tenfold dilutions of the virus suspension were mixed with an equal volume of a 1 : 32 or 1 : 50 dilution of immune ascitic fluid and, after holding at 4 °C for 1 h, 0.1 ml volumes of the mixtures were inoculated into the cultures of BGMK ceils. The unneutralized virus from the highest virus dilution used was examined for resistance to neutralization by the selecting monoclonal antibody. In some cases, two adsorptions with monoclonal antibody were required to select a neutralization-resistant variant. Variants were designated by the monoclonal antibody used for their selection. Variants M-3, M-4, M-5, M-6, M-7, M-8 and M-10 were selected from the Mil strain with respective monoclonal antibodies produced to the Mil strain, while variants M-J 1 and M-J2 were selected from the Mil strain with monoclonal antibodies produced to the JVB strain. The variant (M-7) was still neutralized to low titre by the selecting antibody. The other variants were completely resistant to neutralization by the selecting antibody.
Histopathology. Development of the murine model for evaluation of myocarditic and cardiotropic properties of CBV-4 strains is described elsewhere (Cao et al., 1984) . Briefly, male BALB/c mice 4 weeks of age were inoculated by the intraperitoneal route with 1 x 104.7 TCIDso of virus, and hearts were harvested after 7 days for histopathological examination and virus isolation.
Sections of formalin-fixed heart tissue were stained with haematoxylin and eosin, and were evaluated according to three categories of pathology: inflammation, necrosis and pericarditis. Lesions were graded on a scale of 1-to 3-plus. A reading of 1-plus indicated one or two lesions per section, 2-plus indicated three to 15 lesions, and 3-plus Coxsackievirus B4 antigenic variation 927 indicated over 15 lesions. Inflammation ranged from small foci of mononuclear cell infiltration in the interstitium to the accumulation of mononuclear cells with necrosis of myofibres. Necrosis referred to single hyperchromatic myofibres with damaged nuclei surrounded by a few mononuclear cells, and some areas of basophilic necrosis with little or no mononuclear cell infiltration. Pericarditis consisted of pathological changes in the pericardium, and in some cases involved subepicardial myofibres in subadjacent areas; histopathology was characterized by a thin layer of mononuclear cell infiltrates in the right ventricle to severe pericardial exudates with areas of subepicardial myocardial necrosis immediately beneath.
RESULTS

Reactivity of monoclonal antibodies with homologous virus strains
A myocarditic field strain of CBV-4 (Mil) was used for production of monoclonal antibodies with the aim of identifying specific antigenic determinants which might be associated with the myocarditic properties of the virus. Monoclonal antibodies produced to the amyocarditic JVB strain were used for comparative purposes. Table 1 shows reactivities of this panel of monoclonal antibodies (immune ascitic fluids) with homologous virus strains by neutralization and indirect IF staining. Of the ten clones of monoclonal antibodies produced to the Mil strain, seven reacted with the homologous virus by neutralization and IF, and three were nonneutralizing antibodies which showed virus-specific activity by IF. Mean titres of the mouse ascitic fluids in neutralization tests ranged from 1 x 103~4 to 1 x 104"88, and mean indirect IF titres ranged from 1 x 104.0o to 1 × 107"83. Two of the three monoclonal antibodies to the JVB strain of CBV-4 had neutralizing activity with titres of 1 x 103.5 and 1 x 104'5, and one was a non-neutralizing antibody. IF titres ranged from 1 x 102 to 1 x 104.
Reactivity of monoclonal antibodies with different strains of.CB V-4
Neutralization reactions of the nine monoclonal antibodies against different strains of CBV-4 are shown in Table 2 . Based upon resistance to neutralization (titres of < 1:32) and neutralization titres > 2.5 log10 units lower than against the homologous virus, the strains could be divided roughly into five different groups as shown in Fig. 1 . Monoclonal antibody 4 neutralized only the homologous Mil strain, The McL field strain was neutralized by none of the monoclonal antibodies, but it was neutralized by polyclonal antibody to the JVB strain. With some of the virus strains, unneutralized virus occasionally 'broke through' at some of the serum dilutions below the antibody endpoint. This occurred most commonly with antibodies 5, J 1 and 10, and might be a reflection of low affinity of the antibody or of antigenic heterogeneity of the test virus. the strains in identical fashion in neutralization and IF assays. For example, antibodies 3 and 8 which neutralized virus strains in group 2 showed minimal reactivity with these viruses by IF, as did antibody 7 against strains in group 3. Conversely, antibody J2 which failed to neutralize the McL strain reacted with the strain by IF staining. Antibody 9 was an interesting nonneutralizing antibody in that it reacted with all of the strains by IF, and thus would appear to be directed toward an antigenic determinant which is highly conserved among CBV-4 strains. On the other hand, antibody J3 showed narrow reactivity.
Identification of functional epitopes for neutralization of the Mil strain of CBV-4
The nine neutralizing antibodies in the panel were used to select antigenic variants from the Mil stock which were no longer neutralized by their respective selecting antibody. The resistant variants were then examined in neutralization tests against each of the neutralizing monoclonal antibodies. If a variant lost reactivity to a number of antibodies simultaneously, the epitopes recognized by these antibodies were considered to be functionally linked. If selection with a given antibody did not result in loss of reactivity with a second antibody, the sites recognized by the two antibodies were considered to be distinct. As shown in Fig. 3 , the monoclonal antibodies served to identify tentatively five distinct antigenic sites functional in neutralization. The site designated as No. 3 may in fact represent overlapping epitopes, and competition studies will be required for conclusive grouping of epitopes within this group. Since monoclonal antibody 7 did not select a completely resistant variant, results were not as clear-cut as with the other variants, but on the basis of reactivity of the M-7 variant with other monoclonal antibodies, it would appear that antibody 7 is directed against an epitope within the group 3 complex.
Immunofluorescence testing of the variants selected with the monoclonal antibodies also identified five antigenic sites recognized by the monoclonal antibodies (Fig. 4) and, again, the site tentatively designated as No. 3 may represent overlapping epitopes. Results obtained by IF staining were similar, but not necessarily identical, to those obtained by neutralization. Antibody J1 which did not neutralize the M-7 variant did show reactivity by IF staining, and conversely J 1 neutralized M-3 but did not react by IF staining. Again, antibody 9 reacted with all of the antigenic variants.
Cardiopathic properties of variants selected with monoclonal antibodies
The antigenic variants selected with the nine neutralizing monoclonal antibodies, together with the parent Mil strain, were evaluated in a murine model system (Cao et al., 1984) to determine whether myocarditic and cardiotropic properties might be associated with antigenic Significantly different from the value obtained with the Mil parent strain at P ~< 0.05 (P values were determined by median and Fisher tests).
variation. Results are summarized in Table 3 . The Mil strain was tested as a control in five animals in each of three experiments from which these data were derived.
The M-5 variant produced a more marked inflammatory reaction than did the parent strain, and four of the variants (M-7, M-8, M-J1 and M-J2) produced less inflammation. Particularly notable was the extensive necrosis produced by the M-4 strain. This was the most marked necrotic response seen in this host system. The M-5, M-6 and M-10 variants also produced more necrosis than did the parent strain. Hearts of mice infected with the M-3, M-7, M-8 and M-J2 variants showed no necrosis. The M-3 variant produced a severe inflammatory reaction, but no necrosis or pericarditis. The M-5 variant produced more extensive histopathology in all three categories than did the parent strain. The mean virus titres in hearts of mice infected with the M-4 and M-10 variants were significantly higher than that of hearts from mice infected with the parent strain, and the mean titre in hearts of mice infected with the M-6 strain was significantly lower (P ~< 0.05). Mean titres of hearts from mice infected with the M-8 and M-JI strains were markedly lower than that of mice infected with the parent strain, but did not reach significance at the P ~< 0.05 level because of the large standard deviations. DISCUSSION Using our panel of nine neutralizing antibodies to CBV-4, we were able to identify five different antigenic variants among nine virus strains. With a panel of 18 neutralizing monoclonal antibodies to JVB, Prabhakar et al. (1982) identified 13 different antigenic variants among field strains of CBV-4. Results of these two studies indicate that wide antigenic variation occurs naturally among field strains of CBV-4, and probably other CBV types as well. The fact that some of the isolates showed 'breakthrough' of unneutralized virus at some of the dilutions of neutralizing antiserum is probably an indication of antigenic heterogeneity within individual field strains of CBV-4.
The rate of mutation of CBV-4 was shown to be as high as 10 -4 when Prabhakar et al. (1982) used monoclonal antibodies to select variants resistant to neutralization by the antibodies. We were also able to select antigenic variants with each of our monoclonal antibodies, which were resistant to neutralization and IF staining by the selecting antibody. Thus, antigenic variation can occur at each of the epitopes recognized by the monoclonal antibodies.
The antigenic variants that we selected permitted us to identify tentatively five antigenic sites functional in neutralization. These results are similar to those of Emini et al. (1983) , who used variants selected with 12 monoclonal antibodies to identify seven individual epitopes for neutralization of poliovirus type 1. Competition studies should define the topological relationships of the epitopes to one another, and should clarify the relationship between the epitopes tentatively placed in 'site No. 3'. Our neutralizing monoclonal antibodies showed similar, but not completely identical, activity in neutralization and IF tests. This is not unexpected, since virus neutralization and binding of antibody in IF staining are not necessarily linked phenomena, and IF staining detects a broader range of activities than does neutralization testing. The monoclonal antibodies will next be used to identify the structural viral proteins containing the sites for neutralization, and to determine the stage(s) of infection at which the antibodies exert their neutralizing activity.
One of the non-neutralizing monoclonal antibodies reacted by IF staining with all of the CBV-4 strains and all of the antigenic variants, and thus would appear to be directed toward an epitope which is highly conserved among strains. This antibody might prove to be a very valuable reagent in immunoassays for detection and identification of CBV-4.
An important finding was the fact that the antigenic variants selected with monoclonal antibodies differed from the parent strain and from one another in their cardiotropic and myocarditic properties in a murine model. This suggests that naturally occurring CBV-4 strains consist of mixed populations of antigenic variants differing in pathological properties, and that antibodies in the host may serve to select viruses with greater or lesser cardiotropic and myocarditic potential. It is of interest that the Bol field strain, a myocarditic strain shown in previous studies (Cao et al., 1984) to produce myocarditis characterized by extensive necrosis, was resistant to neutralization by antibodies 4 and 10 which selected variants which produced histopathology characterized by marked necrosis. The identification of specific antigenic determinants which can be associated with cardiopathology of CBV-4 viruses will have important implications in elucidating the pathological or immunopathological role of CBV-4 in human heart disease, and possibly in providing a rational basis for immunoprophylaxis.
